Trial Profile
A Phase 2 Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Single Intrathecal Preoperative Administration of Brivoligide Injection in Patients With a Pain Catastrophizing Scale Score ≥16 Undergoing Unilateral Total Knee Arthroplasty
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2020
Price :
$35
*
At a glance
- Drugs Brivoligide (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Adynxx
- 09 Jul 2020 Planned End Date changed from 15 Jun 2020 to 1 Feb 2022.
- 09 Jul 2020 Planned primary completion date changed from 1 Jun 2020 to 1 Jan 2022.
- 09 Jul 2020 Planned initiation date changed from 1 Oct 2019 to 1 Jan 2021.